Trial intelligence / Profile preview

Efficacy of reduced coenzyme Q10 (ubiquinol) in dementia

jRCTs061180062Completed

Sponsor
Kaneka
Start
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Dementia, Alzheimer's disease (AD), vascular dementia and 3 more comparing Ubiquinol with Placebo (2 arms). Started Feb 2017; status: completed.

02

Drugs

coenzyme q10
03

Conditions

DementiaAlzheimer's disease (AD)vascular dementiadementia with Lewy bodies (DLB)frontotemporal dementia (FTD)

Beyond the preview

Go deeper on jRCTs061180062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs061180062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call